The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

“Our preclinical research was recently published in the peer-reviewed Nature Communications and Proceedings of the National Academy of Sciences.” Up to 60 people will be tested in the Phase 2 ...

Preclinical research has suggested radiation-emitting ... could effectively treat these tumors. In a Phase I clinical trial reported in Nature Communications, two researchers from UT Southwestern ...

The oral presentation outlined new evidence further supporting the disease-modifying activity of GT-02287 in preclinical models ... the design of the ongoing Phase 1b clinical study of GT-02287 ...

Private Placement of US$6 Million to fund additional pre-clinical research, Phase 1 and Phase 2a clinical studiesUS$20 Million additional option included in Private Placement to fund the Phase 3 clini ...

Preclinical research has consistently shown that Decoy20 ... to test that in patients for the first time. While this initial phase will focus on safety and tolerability, we are laying the ...

INDIANAPOLIS — GeniPhys, a preclinical-stage company developing regenerative collagen polymeric biomaterials for soft tissue restoration, has been awarded a $500,000 National Science Foundation (NSF) ...

We are proud to showcase a batch of preclinical research findings at this year's ... applications under regulatory review, 3 assets in Phase III or pivotal clinical trials and 16 more molecules ...

The INFLAM MOTION Study is a Phase 2a multicenter ... and anabolic benefits of GLP-1. Preclinical studies suggest that 4P004 may slow disease progression and improve joint function by modulating ...

Phase 1b study ongoing to assess safety ... further supporting the disease-modifying activity of GT-02287 in preclinical models of both GBA1 and idiopathic Parkinson's disease (PD).